EVE.L Regulatory News (EVE)

eve Sleep plc

("eve" or the "Company")

Exercise of share options, Director shareholding

eve Sleep, the direct to consumer sleep wellness brand operating in the UK, Ireland and France announces that it has issued and allotted 187,500 ordinary shares of 0.1p each in the capital of the Company ("Ordinary Shares") pursuant to the exercise of share options by Chief Executive Officer Cheryl Calverley.

Following the exercise, Cheryl has an interest in 187,500 Ordinary Shares and 4,312,500 options. The Ordinary Shares represent 0.07% of the entire current ordinary share capital of the Company.

The Company also announces, that alongside the exercise by Cheryl, the Company has issued and allotted an additional 2,444,444 Ordinary Shares pursuant to the exercise of share options by James Sturrock, NED of the Company. Following the exercise, James has an interest in 2,497,194 Ordinary Shares and 6,355,556 options. The Ordinary Shares represent 0.92% of the entire current ordinary share capital of the Company.

Application has been made to the London Stock Exchange for the 2,631,944 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence on or around the 6 July 2020.

The Company advises that, following Admission, the Company's issued share capital will be 272,342,554 Ordinary Shares all with voting rights. The above figure of 272,342,554 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

For further information, please contact:

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.